Gyne Pharma Integration: GnRH Analogs, Synthetic LH/FSH, and hCG

Gyne Pharma Integration

This lecture focuses on integrating gynecology with pharmacology, emphasizing the importance of understanding the menstrual cycle, hormones, and related medications. A strong grasp of gyne physiology, anatomy, and pharmacology is crucial for simplifying gynecology.

Key Topics

  1. GnRH Analogs: Medications mimicking Gonadotropin-Releasing Hormone to modulate LH and FSH secretion.

  2. Synthetic LH and FSH: Lab-created Luteinizing Hormone and Follicle-Stimulating Hormone for infertility treatments.

  3. Synthetic Estrogens: Artificially produced estrogens used in hormone replacement therapy and contraception.

  4. SERMs: Selective Estrogen Receptor Modulators affecting estrogen receptors in different tissues.

  5. Anti-Estrogens: Drugs countering estrogen effects, often used in breast cancer treatment.

  6. Progesterone: A key hormone in the menstrual cycle and pregnancy, used in contraception and hormone therapy.

  7. Selective Progesterone Receptor Modulators: Medications that selectively affect progesterone receptors for contraception and uterine conditions.

  8. Anti-Androgens: Drugs blocking the effects of androgens, used in treating conditions like hirsutism and prostate cancer.

The lecture is divided into two parts:

  • Part 1: GnRH analogs, synthetic LH/FSH, and hCG.

  • Part 2: Estrogens, progesterone, and related drugs.

Reproductive Physiology

Female

  • Hypothalamus: Releases GnRH in a pulsatile manner at puberty, influencing the menstrual cycle.

  • Anterior Pituitary: GnRH acts on basophils to release FSH and LH (gonadotropins), also in a pulsatile manner. These hormones are crucial for ovarian function.

  • Ovaries: FSH stimulates granulosa cells to release estrogen, promoting follicular growth. LH induces ovulation, and the corpus luteum releases progesterone after ovulation, preparing the uterus for implantation.

  • Two-Cell, Two-Gonadotropin Theory: LH acts on theca cells to produce androgens, which are then converted to estrogen in granulosa cells under FSH influence. This is essential for estrogen synthesis in the ovaries.

  • FSH Function: Primarily follicular growth and estrogen production.

  • LH Function: Primarily ovulation and progesterone production in the corpus luteum.

Male

  • Hypothalamus: Releases GnRH in a pulsatile manner at puberty, initiating spermatogenesis.

  • Anterior Pituitary: GnRH acts on to release LH and FSH, stimulating testicular function.

  • Leydig Cells: LH acts on Leydig cells to release testosterone, which is essential for spermatogenesis, muscle development, and secondary sexual characteristics.

Feedback Loops

  • Positive Feedback: GnRH stimulates the anterior pituitary, leading to LH and FSH release, which stimulates the ovaries to release estrogen and progesterone. This positive feedback is crucial for the LH surge during ovulation.

  • Negative Feedback: Estrogen inhibits GnRH release, reducing LH and FSH levels, maintaining hormonal balance. Testosterone also inhibits GnRH release in males.

  • Exception: High estrogen levels can create a positive feedback loop, causing an LH surge, which is essential for ovulation.

Hypogonadotropic Hypogonadism

  • Cause: Decreased GnRH (hypothalamus issue) or anterior pituitary problems, leading to reduced LH and FSH, resulting in low sex hormone levels.

  • Result: Decreased estrogen levels, leading to amenorrhea, infertility, and other symptoms in females.

Hypergonadotropic Hypogonadism

  • Cause: Ovarian failure despite normal hypothalamic and pituitary function, often due to genetic conditions or premature ovarian failure.

  • Mechanism: Hypothalamus releases GnRH, stimulating the pituitary to release LH and FSH. However, the failed ovary cannot produce estrogen.

  • Hormone Levels: Low estrogen levels eliminate negative feedback, causing increased GnRH, LH, and FSH.

LH and FSH Deficiencies

Females

  • Effects: Follicles fail to grow, no ovulation (anovulation), and reduced estrogen, leading to delayed puberty, infertility, and menstrual irregularities.

Males

  • Effects: Delayed puberty, decreased testosterone, and impaired spermatogenesis (oligospermia), leading to infertility and reduced libido.

Increased LH and FSH

Females (with Normal Ovaries)

  • Effects: Increased estrogen can cause precocious puberty, fibroids, endometriosis, endometrial cancer, and ovarian cancer. High levels can stimulate excessive tissue growth.

  • Increased Androgens: High LH can lead to increased androgen production, causing hirsutism (male-pattern hair growth), acne, and virilization.

Males

  • Effects: Precocious puberty and increased risk of prostate cancer due to elevated testosterone levels. Prolonged exposure can lead to significant health issues.

GnRH Analogs

  • Source: Synthetic versions of natural GnRH, designed to mimic or block GnRH activity.

  • Pulsatile Administration: Mimics the body's natural GnRH release, increasing LH and FSH, thus increasing estrogen (females) and testosterone (males). Used to stimulate ovulation and spermatogenesis.

  • Mechanism: Acts on GnRH receptors in the pituitary, modulating LH and FSH secretion.

  • Continuous Administration: Initially increases LH and FSH but then downregulates GnRH receptors, leading to decreased LH and FSH, thus decreasing estrogen (females) and testosterone (males). Used to suppress hormone production in various conditions.

  • Initial Flare-Up: Continuous GnRH administration causes an initial increase in LH and FSH before suppression, which can exacerbate symptoms temporarily.

Indications for Pulsatile GnRH

  • Delayed puberty.

  • Anovulation.

  • Hypogonadotropic hypogonadism.

  • Kallmann syndrome (GnRH deficiency plus anosmia).

  • Sexual infantilism.

Side Effects of Pulsatile GnRH

  • Multiple pregnancy/multifetal gestation.

  • Ovarian hyperstimulation syndrome (OHSS).

  • Potential increased risk of ovarian cancer (due to increased ovulation).

Indications for Continuous GnRH (or GnRH Antagonists)

  • Precocious puberty.

  • Fibroids.

  • Endometriosis.

  • Hirsutism.

  • Prostate cancer.

  • Estrogen receptor-positive breast cancer.

GnRH Analogs Available

  • Leuprolide.

  • Goserelin

  • Buseriline.

  • Nafarelin.

  • Triptorelin.

    • Most common route of administration is subcutaneous injections due to high first pass metabolism.

    • Buseriline and nafarelin can be given intranasally.

    • GnRH analogs act as both activators and suppressors, with an initial flare reaction when used as suppressors.

GnRH Antagonists

  • Action: Always act as suppressors without an initial flare reaction, providing immediate hormone suppression.

  • Administration: Orally active but expensive.

  • Examples: Ganirelix, cetrorelix, relugolix, and elagolix (suffix -lix).

  • Common Use: Cetrorelix in assisted reproductive technology.

Adverse Effects of Continuous GnRH or GnRH Antagonists
Males

  • Decreased testosterone: Loss of libido, impotence, reduced muscle mass, and osteoporosis.

Females

  • Decreased estrogen: Infertility, anovulation, hot flushes, osteoporosis, and vaginal dryness.

Add-Back Therapy

  • Purpose: To counteract side effects (e.g., osteoporosis) when using continuous GnRH analogs, improving patient tolerance.

  • Method: Administering small amounts of estrogen, often via norethindrone (a first-generation progesterone with some estrogenic activity).

Synthetic LH and FSH (Human Menopausal Gonadotropin - HMG)

  • Source: Urine of postmenopausal females, providing a natural source of gonadotropins.

  • Composition: 75 international units of LH and FSH, used to stimulate ovarian function.

Uses of HMG

  • Ovulation induction in females with hypogonadotropic hypogonadism.

  • Second-line drug for ovulation induction in PCOS patients (where LH is already high).

  • IVF cycles for hyperovulation.

Risks and Drawbacks of HMG

  • Multi-fetal gestation (30% chance).

  • Ovarian hyperstimulation syndrome (OHSS) (5-15% chance).

  • Potential increased risk of ovarian cancer.

Human Chorionic Gonadotropin (hCG)

  • Source: Urine of pregnant females, mimicking the effects of LH.

  • Action: Functionally similar to LH, used to trigger ovulation and support the corpus luteum.

Uses of hCG

  • Ovulation trigger (mimics LH surge).

  • Luteal phase support in patients with hypogonadotropic hypogonadism who conceive via HMG (to maintain corpus luteum).

Administration

  • Ovulation trigger: 5,000 international units.

  • Luteal phase support: 2,000 international units every 3-4 days.